CRA International (CRAI) Form 144 Discloses 7,500-Share Sale, Recent Insider Sales Total 17,500
Rhea-AI Filing Summary
Form 144 notice filed for CRA International, Inc. (CRAI). The filer proposes to sell 7,500 shares of common stock through Robert W. Baird on 08/14/2025 with an aggregate market value reported as $1,401,883.50. The filing shows the 7,500 shares were acquired by vesting of RSUs/PRSUs in 2017 and 2018 as compensation (3/12/2018: 3,799 shares; 11/12/2018: 2,632 shares; 11/14/2017: 1,069 shares). The filer has reported multiple sales in the past three months by Paul A. Maleh totaling 17,500 shares for gross proceeds of approximately $3,294,452.93 across sales on 05/20/2025, 08/07/2025, and 08/08/2025. The form includes the standard representation that the seller is not aware of any undisclosed material adverse information.
Positive
- Acquisition provenance disclosed: All 7,500 shares were acquired via RSU/PRSU vesting as compensation, with dates and amounts provided.
- Broker identified: Sale to be executed through Robert W. Baird, providing execution transparency.
- Seller representation included: The filing contains the required seller representation that there is no undisclosed material adverse information.
Negative
- Significant recent insider sales: Paul A. Maleh sold 17,500 shares in the past three months for gross proceeds totaling approximately $3,294,452.93, which could be viewed negatively by some investors.
- No indication of 10b5-1 plan: The form does not specify a trading plan adoption date, so these sales may not be pursuant to an established plan.
Insights
TL;DR: Routine insider sale filing; material only for disclosure—no new operational data disclosed.
The Form 144 documents an insider sale of 7,500 shares on 08/14/2025 executed through Robert W. Baird, with acquisition traced to RSU/PRSU vesting events in 2017 and 2018. The filing itself supplies no operating results, guidance, or confidential developments. The notable element is the volume of recent insider sales by Paul A. Maleh (17,500 shares in the past three months) which may be relevant to market participants monitoring insider liquidity but does not by itself indicate company operational issues. Impact on float and share count is minimal relative to outstanding shares of 6,583,794 but could influence short-term supply-demand dynamics around the sale dates.
TL;DR: Disclosure appears consistent with Rule 144 requirements; includes acquisition detail and representation about material information.
The filing includes required acquisition provenance for the securities (dates, nature as RSU/PRSU vesting, compensation) and specifies the broker and intended sale date, satisfying key Rule 144 disclosure elements. The signer affirms lack of undisclosed material adverse information and notes potential Rule 10b5-1 plan fields are present but not populated. There is no explicit evidence in the filing of a 10b5-1 plan or plan adoption date. From a compliance standpoint, the document is routine but market participants should note the recent concentrated sales activity by the named insider.